Serum Metabolomic Profiling and Clinical Phenotypes in Parkinson's Disease: A Case–Control Study
Lipids · 11.11.2026
DOI: 10.1002/lipd.70092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lipids, online erschienen am 11.11.2026. Verfasst von Jiale Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China. Die Arbeit nennt 31 Literaturangaben. Gefördert von: High-performance Computing Public Platform (Shenzhen Campus) of Sun Yat-sen University, Shenzhen Natural Science Foundation, Guangdong Science and Technology Program.
Abstract (Originalsprache)
Parkinson's disease (PD) is characterized by heterogeneous motor and non‐motor symptoms, but serum metabolic features related to this variability remain unclear. To address this, this small‐scale study investigated serum metabolic alterations in patients with PD and explored their relationships with clinical features. Serum samples from 9 patients with PD and 9 age‐ and sex‐matched normal controls were analyzed using untargeted UPLC–MS/MS metabolomics. OPLS‐DA was used for exploratory group discrimination. Candidate metabolites were selected according to OPLS‐DA‐derived variable importance in projection (VIP) values, nominal p values, and fold‐change criteria (VIP > 1.0, nominal p < 0.05, and |log2FC| > 0.585). In addition, pathway enrichment analysis and exploratory correlation and regression analyses were performed to evaluate the relationships between metabolite changes and clinical characteristics. Using these nominal screening criteria, 169 candidate metabolites were identified, including 84 upregulated and 85 downregulated metabolites. Pathway analysis suggested potential involvement of steroid hormone biosynthesis, bile secretion, biosynthesis of unsaturated fatty acids, and neuroactive ligand‐receptor interaction. Within these pathways, candidate metabolites, including docosahexaenoic acid, 8Z,11Z,14Z‐eicosatrienoic acid, 5α‐dihydrotestosterone, 2‐methoxyestradiol, cortisol, chenodeoxycholic acid, deoxycholate, and adrenic acid, showed exploratory associations with clinical features related to gastrointestinal symptoms, non‐motor manifestations, and motor‐related clinical features. Overall, this study suggests that alterations in serum steroid hormones, bile acids, and unsaturated fatty acids may be related to clinical manifestations of PD, although these findings require validation in larger cohorts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China.
- Guangdong Engineering Technology Research Center of Nutrition Transformation, Sun Yat-Sen University, Shenzhen, China.
- Department of Neurology, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.
ORCID-Profile: Jiale Li, Rulin Geng, Yiqiang Zhan, Enxiang Tao
Förderung
- High-performance Computing Public Platform (Shenzhen Campus) of Sun Yat-sen University
- Shenzhen Natural Science Foundation
- Guangdong Science and Technology Program
- Shenzhen Science and Technology Program
- Natural Science Foundation of Shenzhen Municipality
- Science and Technology Planning Project of Guangdong Province
Zitieren
APA
Li, J., Geng, R., Zhang, J., Zhan, Y., Lin, D., & Tao, E. (2026). Serum Metabolomic Profiling and Clinical Phenotypes in Parkinson's Disease: A Case–Control Study. Lipids. https://doi.org/10.1002/lipd.70092
Vancouver
Li J, Geng R, Zhang J, Zhan Y, Lin D, Tao E. Serum Metabolomic Profiling and Clinical Phenotypes in Parkinson's Disease: A Case–Control Study. Lipids. 2026. doi:10.1002/lipd.70092
BibTeX
@article{Li2026,
author = {Li, Jiale and Geng, Rulin and Zhang, Jieli and Zhan, Yiqiang and Lin, Danyu and Tao, Enxiang},
title = {Serum Metabolomic Profiling and Clinical Phenotypes in Parkinson's Disease: A Case–Control Study},
journal = {Lipids},
year = {2026},
doi = {10.1002/lipd.70092}
}
EUVIMED